Psychedelic therapy is a technique that involves the use of drugs that produce a psychedelic effect in order to assist in the psychotherapy process.
The U.S. Food and Drug Administration (FDA) named psilocybin-assisted therapy as a “breakthrough therapy.” Over the last two decades, researchers have received approval from governmental authorities to conduct trials on the use of the psychedelic substances to treat various conditions. What researchers have found is that psychedelic substances can have beneficial therapeutic effects. According to the research, there are a number of potential applications for psychedelic therapy such as anxiety, depression, substance use, alcohol use, and PTSD. At present, there are multiple clinical trials on psychedelic assisted therapy, some in phase II and III.
While psychedelics have the potential to help treat a number of mental health conditions, it is important to remember that these are powerful substances that can produce profound mind-altering effects. While psychedelic assisted psychotherapy is generally considered safe, there are potential risks such as negative psychological reactions, danger in self-treatment, and personality changes.
Dr. Ingmar Gorman Interview
Dr. Ingmar Gorman who is a psychologist who specializes in assisting populations who have a relationship with psychedelics and the co-founder of Fluence which provides professional education to licensed clinicians in psychedelic-assisted psychotherapy and integration. Dr. Gorman is the site co-principal investigator and clinician on a MAPS Phase 3 clinical trial studying MDMA-assisted psychotherapy for post-traumatic stress disorder.
Click the links below to find out more about Psychedelic-Assisted Psychotherapy.